Torthaí cuardaigh - Edelgard Lindhoff‐Last
- 1 - 12 toradh as 12 á dtaispeáint
-
1
-
2
Treatment of 51 pregnancies with danaparoid because of heparin intolerance de réir Hans-Joachim Kreutzenbeck, Harry Magnani, Edelgard Lindhoff‐Last
Foilsithe / Cruthaithe 2004Revisão -
3
Laboratory testing of rivaroxaban in routine clinical practice: When, how, and which assays de réir Edelgard Lindhoff‐Last, Jack Ansell, Theodore E. Spiro, M Samama
Foilsithe / Cruthaithe 2013Revisão -
4
Use of native or platelet count adjusted platelet rich plasma for platelet aggregation measurements de réir H. Mani, Beate Luxembourg, Christina Kläffling, M. Erbe, Edelgard Lindhoff‐Last
Foilsithe / Cruthaithe 2005Artigo -
5
Incidence and clinical relevance of heparin‐induced antibodies in patients with deep vein thrombosis treated with unfractionated or low‐molecular‐weight heparin de réir Edelgard Lindhoff‐Last, Roumen Nakov, Frank Misselwitz, Hans‐Klaus Breddin, Rupert Bauersachs
Foilsithe / Cruthaithe 2002Artigo -
6
Incidence and causes of heparin-induced skin lesions de réir Marc Schindewolf, Sandra L. Schwaner, Manfred Wolter, H. Kroll, Andreas Recke, R. Kaufmann, Wolf‐Henning Boehncke, Edelgard Lindhoff‐Last, Ralf J. Ludwig
Foilsithe / Cruthaithe 2009Artigo -
7
Intraarterial Administration of Bone Marrow Mononuclear Cells in Patients With Critical Limb Ischemia de réir Dirk Walter, Hans Krankenberg, Jörn O. Balzer, Christoph Kalka, Iris Baumgärtner, Michael Schlüter, Torsten Tonn, Florian Seeger, Stefanie Dimmeler, Edelgard Lindhoff‐Last, Andreas M. Zeiher
Foilsithe / Cruthaithe 2011Artigo -
8
International Council for Standardization in Haematology (ICSH) Recommendations for Laboratory Measurement of Direct Oral Anticoagulants de réir Robert C. Gosselin, Dorothy M. Adcock, Shannon M. Bates, Jonathan Douxfils, Emmanuel J. Favaloro, Isabelle Gouin‐Thibault, Cecilia Guillermo, Yohko Kawai, Edelgard Lindhoff‐Last, Steve Kitchen
Foilsithe / Cruthaithe 2018Artigo -
9
2021 Update of the International Council for Standardization in Haematology Recommendations for Laboratory Measurement of Direct Oral Anticoagulants de réir Jonathan Douxfils, Dorothy M. Adcock, Shannon M. Bates, Emmanuel J. Favaloro, Isabelle Gouin‐Thibault, Cecilia Guillermo, Yohko Kawai, Edelgard Lindhoff‐Last, Steve Kitchen, Robert C. Gosselin
Foilsithe / Cruthaithe 2021Revisão -
10
Long-term outcome in vaccine-induced immune thrombocytopenia and thrombosis de réir Linda Schönborn, Sabrina E. Seck, Thomas Thiele, Lars Kaderali, Till Hoffmann, A Hlinka, Edelgard Lindhoff‐Last, Uwe Völker, Kathleen Selleng, Alessandra Buoninfante, Marco Cavaleri, Andreas Greinacher
Foilsithe / Cruthaithe 2023Artigo -
11
Use of Fondaparinux Off-Label or Approved Anticoagulants for Management of Heparin-Induced Thrombocytopenia de réir Marc Schindewolf, Julia Steindl, Jan Beyer‐Westendorf, Sebastian Schellong, Pascal M. Dohmen, Johannes Brachmann, Katharina Madlener, Bernd Pötzsch, Robert Klamroth, Johannes Hankowitz, Norbert Banik, Sonja Eberle, Markus Müller, Stefan Kropff, Edelgard Lindhoff‐Last
Foilsithe / Cruthaithe 2017Artigo -
12
Anti-PF4 immunothrombosis without proximate heparin or adenovirus vector vaccine exposure de réir Linda Schönborn, Olga Esteban, Jan Wesche, Paulina Dobosz, Marta Broto, Sara Rovira Puig, Jessica Fuhrmann, Raquel Torres, Josep Serra, Roser Llevadot, Marta Palicio, Jing Jing Wang, Tom P. Gordon, Edelgard Lindhoff‐Last, Till Hoffmann, Lorenzo Alberio, Florian Länger, Christian Boehme, Eugenia Biguzzi, Leonie Grosse, Matthias Endres, Thomas Liman, Thomas Thiele, Theodore E. Warkentin, Andreas Greinacher
Foilsithe / Cruthaithe 2023Artigo
Uirlisí cuardaigh:
Ábhair a bhaineann le hábhar
Internal medicine
Medicine
Heparin
Platelet
Surgery
Anesthesia
Apixaban
Atrial fibrillation
Dabigatran
Rivaroxaban
Thrombosis
Warfarin
Coagulation
Immunology
Intensive care medicine
Antibody
Coagulation testing
Computer science
Edoxaban
Gastroenterology
Heparin-induced thrombocytopenia
Incidence (geometry)
Lepirudin
Medical physics
Operating system
Optics
Pathology
Pharmacology
Physics
Platelet factor 4